Hye‐Lin Kim

1.3k total citations
54 papers, 946 citations indexed

About

Hye‐Lin Kim is a scholar working on Epidemiology, Physiology and Molecular Biology. According to data from OpenAlex, Hye‐Lin Kim has authored 54 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 12 papers in Physiology and 11 papers in Molecular Biology. Recurrent topics in Hye‐Lin Kim's work include Liver Disease Diagnosis and Treatment (13 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers) and Adipose Tissue and Metabolism (10 papers). Hye‐Lin Kim is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers) and Adipose Tissue and Metabolism (10 papers). Hye‐Lin Kim collaborates with scholars based in South Korea, United States and Taiwan. Hye‐Lin Kim's co-authors include Jae‐Young Um, Jinbong Park, Yunu Jung, Kwang Seok Ahn, Eui‐Kyung Lee, Seung‐Heon Hong, Dong‐Hyun Youn, Mi‐Young Jeong, JongWook Kang and Young‐Suk Lim and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Hye‐Lin Kim

50 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hye‐Lin Kim South Korea 20 300 266 204 145 111 54 946
Mevlüt Başkol Türkiye 17 291 1.0× 263 1.0× 99 0.5× 143 1.0× 180 1.6× 50 1.0k
José Alcaraz‐Quiles Spain 17 441 1.5× 248 0.9× 242 1.2× 192 1.3× 120 1.1× 23 1.1k
Keishi Kanno Japan 18 363 1.2× 359 1.3× 117 0.6× 197 1.4× 144 1.3× 64 1.1k
Gabriela Gutiérrez‐Reyes Mexico 18 359 1.2× 164 0.6× 116 0.6× 218 1.5× 89 0.8× 54 927
Mehmet Yalnız Türkiye 20 527 1.8× 223 0.8× 100 0.5× 263 1.8× 166 1.5× 59 1.1k
Xiude Fan China 23 449 1.5× 355 1.3× 95 0.5× 147 1.0× 100 0.9× 91 1.3k
Marica Cariello Italy 24 332 1.1× 632 2.4× 239 1.2× 131 0.9× 133 1.2× 54 1.6k
Teresa Muñoz‐Yagüe Spain 16 499 1.7× 327 1.2× 186 0.9× 165 1.1× 141 1.3× 24 1.0k
Tawanda M. Nyambuya South Africa 22 274 0.9× 299 1.1× 298 1.5× 38 0.3× 172 1.5× 51 1.1k

Countries citing papers authored by Hye‐Lin Kim

Since Specialization
Citations

This map shows the geographic impact of Hye‐Lin Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hye‐Lin Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hye‐Lin Kim more than expected).

Fields of papers citing papers by Hye‐Lin Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hye‐Lin Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hye‐Lin Kim. The network helps show where Hye‐Lin Kim may publish in the future.

Co-authorship network of co-authors of Hye‐Lin Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Hye‐Lin Kim. A scholar is included among the top collaborators of Hye‐Lin Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hye‐Lin Kim. Hye‐Lin Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Suk‐Chan, Gi‐Ae Kim, Young‐Suk Lim, Hye‐Lin Kim, & Eui‐Kyung Lee. (2025). Association between everolimus combination therapy and cancer risk after liver transplantation: A nationwide population-based quasi-cohort study. American Journal of Transplantation. 25(6). 1285–1295. 1 indexed citations
2.
Park, Huiyul, Eileen L. Yoon, Mimi Kim, et al.. (2024). Cost‐effectiveness study of FIB‐4 followed by transient elastography screening strategy for advanced hepatic fibrosis in a NAFLD at‐risk population. Liver International. 44(4). 944–954. 13 indexed citations
3.
Kim, Mimi, Eileen L. Yoon, Huiyul Park, et al.. (2024). Limited use of FIB‐4 index in patients under 65 years of age with type 2 diabetes mellitus. Hepatology Research. 55(4). 505–514. 1 indexed citations
4.
Park, Hae‐Young, Jin‐Won Kwon, Hye‐Lin Kim, et al.. (2023). Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens. Journal of Korean Medical Science. 38(21). e167–e167. 1 indexed citations
5.
Park, Huiyul, Eileen L. Yoon, Mimi Kim, et al.. (2023). Diagnostic performance of the fibrosis-4 index and the NAFLD fibrosis score for screening at-risk individuals in a health check-up setting. Hepatology Communications. 7(10). 4 indexed citations
6.
Yang, Jae Wook, et al.. (2023). Pharmacist’s Intervention Activities for Drug-related Problems in a Community Pharmacy. Yakhak Hoeji. 67(2). 128–136.
7.
Kim, Hye‐Lin, You Mee Ahn, So Min Lee, et al.. (2022). Anti-Obesity Effects of Aqueous Extracts of Sunbanghwalmyung-Eum in High-Fat- and High-Cholesterol-Diet-Induced Obese C57BL/6J Mice. Nutrients. 14(14). 2929–2929. 4 indexed citations
8.
Nam, Jin Hyun, et al.. (2022). Real-world association of adherence with outcomes and economic burden in patients with tuberculosis from South Korea claims data. Frontiers in Pharmacology. 13. 918344–918344. 2 indexed citations
11.
Kim, Hye‐Lin, et al.. (2020). Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B. Gut. 70(11). 2172–2182. 26 indexed citations
12.
Kim, Sung Hwan, Hyun Jeong Kim, Jung Mi Lim, et al.. (2020). Analysis of Work Activities and Proportion of Time Performed by Hospital Pharmacists. 37(2). 126–150. 6 indexed citations
13.
Yang, So‐Young, et al.. (2020). Haematological cancer versus solid tumour end-of-life care: a longitudinal data analysis. BMJ Supportive & Palliative Care. 14(e1). e837–e844. 5 indexed citations
14.
Park, Chul B., et al.. (2020). Price Reduction of Anticancer Drugs from 2007 to 2019 in South Korea: The Impact of Pharmaceutical Cost-Containment Policies. Applied Health Economics and Health Policy. 19(3). 439–450. 4 indexed citations
15.
Song, Hyun Jin, Jin Hyun Nam, So‐Young Yang, et al.. (2018). Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea. BMJ Open. 8(3). e020825–e020825. 49 indexed citations
16.
Youn, Dong‐Hyun, Jin Bong Park, Hye‐Lin Kim, et al.. (2018). Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro. Frontiers in Pharmacology. 9. 541–541. 33 indexed citations
17.
Jung, Yunu, Jin Bong Park, Hye‐Lin Kim, et al.. (2016). Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase. Scientific Reports. 6(1). 31906–31906. 40 indexed citations
19.
Lee, Min‐Young, et al.. (2014). Cost-effectiveness of Tolvaptan for Euvolemic or Hypervolemic Hyponatremia. Clinical Therapeutics. 36(9). 1183–1194. 6 indexed citations
20.
Kang, Sung‐Bum, et al.. (2007). The efficacy and adverse effects of topical phenylephrine for anal incontinence after low anterior resection in patients with rectal cancer. International Journal of Colorectal Disease. 22(11). 1319–1324. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026